1. What’s New in Gastric and Esophageal Cancers

   • Kenneth Tanabe

   Gastrointestinal Oncology 08 September 2016 Pages: 3773 - 3773

2. Advances in Imaging and Endoluminal Therapies for Early Esophageal and Gastric Cancers

   • Neil Sengupta
   • Mandeep S. Sawhney

   Gastrointestinal Oncology 27 July 2016 Pages: 3774 - 3779

3. What’s the Best Way to Treat GE Junction Tumors? Approach Like Gastric Cancer

   • John T. Mullen
   • Eunice L. Kwak
   • Theodore S. Hong

   Gastrointestinal Oncology 26 July 2016 Pages: 3780 - 3785

   

4. Exploiting Molecular and Immune Biology of Gastric and Gastroesophageal Adenocarcinomas to Discover Novel Therapeutic Targets

   • Elena Elimova
   • Shumei Song
   • Jaffer A. Ajani

   Gastrointestinal Oncology 08 August 2016 Pages: 3786 - 3791

5. Minimally Invasive Gastric Surgery

   • Gabriel Herrera-Almario
   • Vivian E. Strong

   Gastrointestinal Oncology 03 August 2016 Pages: 3792 - 3797

6. Gastroesophageal Junction Tumors

   • Nabil Rizk

   Thoracic Oncology 04 August 2016 Pages: 3798 - 3800

7. Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ

   • Monica Morrow
   • Kimberly J. Van Zee
   • Meena S. Moran

   Breast Oncology Open access 15 August 2016 Pages: 3801 - 3810

8. The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis

   • M. Luke Marinovich
   • Lamiae Azizi
   • Nehmat Houssami

   Breast Oncology 15 August 2016 Pages: 3811 - 3821

   

9. Type and Extent of Surgery for Screen-Detected and Interval Cancers at Blinded Versus Nonblinded Double-Reading in a Population-Based Screening Mammography Program

   • Roy J. P. Weber
   • Rob M. G. van Bommel
   • Lucien E. M. Duijm

   Breast Oncology 22 June 2016 Pages: 3822 - 3830

10. Different Prognostic Implications of Residual Disease After Neoadjuvant Treatment: Impact of Ki 67 and Site of Response

    • Sebastian Diaz-Botero
    • Martin Espinosa-Bravo
    • Isabel T. Rubio

    Breast Oncology 29 June 2016 Pages: 3831 - 3837

    

11. Mucocele-Like Lesions of the Breast: Rate of Upstaging and Cancer Development

    • Waleed O. Gibreel
    • Judy C. Boughey

    Breast Oncology 30 June 2016 Pages: 3838 - 3842

    

12. Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer

    • Evelyn Jiagge
    • Aisha Souleiman Jibril
    • Lisa A. Newman

    Breast Oncology 28 July 2016 Pages: 3843 - 3849

    

13. Oncofertility Knowledge, Attitudes, and Practices of Canadian Breast Surgeons

    • Ellen Warner
    • Samantha Yee
    • May Lynn Quan

    Breast Oncology 18 July 2016 Pages: 3850 - 3859

    

14. Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1–2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy

    • Shih-Fan Lai
    • Yu-Hsuan Chen
    • Chiun-Sheng Huang

    Breast Oncology 19 July 2016 Pages: 3860 - 3869

    

15. Body Mass Index and Locoregional Recurrence in Women with Early-Stage Breast Cancer

    • Laura E. G. Warren
    • Jennifer A. Ligibel
    • Jennifer R. Bellon

    Breast Oncology 22 July 2016 Pages: 3870 - 3879

16. Adjuvant Radiotherapy in Early-Stage Breast Cancer: Evidence-Based Options

    • Chirag Shah
    • Rahul Tendulkar
    • Frank Vicini

    Breast Oncology 24 August 2016 Pages: 3880 - 3890

    

17. Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer

    • Stéphanie Chemama
    • Mohamed Amine Bayar
    • Sami Antoun

    Colorectal Cancer 28 June 2016 Pages: 3891 - 3898

18. Effect of Neoadjuvant Radiation Dose and Schedule on Nodal Count and Its Prognostic Impact in Stage II–III Rectal Cancer

    • Wim Ceelen
    • Wouter Willaert
    • On behalf of PROCARE

    Colorectal Cancer 05 July 2016 Pages: 3899 - 3906

    

19. Risk Stratification in Patients with Stage II Colon Cancer

    • Ramzi Amri
    • Jonathan England
    • David L. Berger

    Colorectal Cancer 05 July 2016 Pages: 3907 - 3914

    

20. Short Chemotherapy-Free Interval Improves Oncological Outcome in Patients Undergoing Two-Stage Hepatectomy for Colorectal Liver Metastases

    • P. Kambakamba
    • M. Linecker
    • M. Lesurtel

    Colorectal Cancer 18 July 2016 Pages: 3915 - 3923

    

21. Immature Colon Carcinoma Transcript-1 (ICT1) Expression Correlates with Unfavorable Prognosis and Survival in Patients with Colorectal Cancer

    • Xinyuan Lao
    • Qingyang Feng
    • Xinyu Qin

    Colorectal Cancer 13 July 2016 Pages: 3924 - 3933

    

22. Variation in the Use of Chemoradiotherapy for Stage II and III Anal Cancer: Analysis of the National Cancer Data Base

    • Cristina B. Geltzeiler
    • Vassiliki L. Tsikitis
    • Kim C. Lu

    Colorectal Cancer 21 July 2016 Pages: 3934 - 3940

    

23. Laparoscopic-Assisted Rectal Surgery for Rectal Cancer Using the Simple Rectum Catcher Device with an Intraoperative Colonoscopy: Results of Our Hospital Study in 203 Patients

    • Akiyo Matsumoto
    • Kaida Arita

    Colorectal Cancer 26 July 2016 Pages: 3941 - 3947

24. Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer

    • Keishi Sugimachi
    • Tae Matsumura
    • Koshi Mimori

    Gastrointestinal Oncology 06 June 2016 Pages: 3948 - 3955

    

25. Significant Role of Palliative Gastrectomy in Selective Gastric Cancer Patients with Peritoneal Dissemination: A Propensity Score Matching Analysis

    • Run-Cong Nie
    • Shi Chen
    • Ying-Bo Chen

    Gastrointestinal Oncology 05 July 2016 Pages: 3956 - 3963

    

26. Using the Comprehensive Complication Index to Assess the Impact of Neoadjuvant Chemoradiotherapy on Complication Severity After Esophagectomy for Cancer

    • Nina Nederlof
    • Annelijn E. Slaman
    • CROSS-Study Group

    Gastrointestinal Oncology Open access 14 June 2016 Pages: 3964 - 3971

    

27. CRS-HIPEC Prolongs Survival but is Not Curative for Patients with Peritoneal Carcinomatosis of Gastric Cancer

    • T. Boerner
    • A. Graichen
    • M. H. Dahlke

    Gastrointestinal Oncology 16 June 2016 Pages: 3972 - 3977

    

28. Digital Glissonectomy: A Safe Perihepatic Peritonectomy

    • Guillaume Passot
    • Bradford J. Kim
    • Olivier Glehen

    Gastrointestinal Oncology 24 June 2016 Pages: 3978 - 3985

    

29. The Multidisciplinary Approach to GI Cancer Results in Change of Diagnosis and Management of Patients. Multidisciplinary Care Impacts Diagnosis and Management of Patients

    • Cheryl Meguid
    • Richard D. Schulick
    • Barish H. Edil

    Gastrointestinal Oncology 24 June 2016 Pages: 3986 - 3990

30. Feasibility of Routine Application of Gadoxetic Acid-Enhanced MRI in Combination with Diffusion-Weighted MRI for the Preoperative Evaluation of Colorectal Liver Metastases

    • Masahiro Tanaka
    • Yoji Kishi
    • Kazuaki Shimada

    Hepatobiliary Tumors 29 June 2016 Pages: 3991 - 3998

    

31. Posttreatment Surveillance in Patients with Prolonged Disease-Free Survival After Resection of Colorectal Liver Metastasis

    • Boris Galjart
    • Eric P. van der Stok
    • Cornelis Verhoef

    Hepatobiliary Tumors Open access 08 July 2016 Pages: 3999 - 4007

    

32. Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk?

    • Mio Kitano
    • Gail W. Davidson
    • Mark Bloomston

    Endocrine Tumors 08 July 2016 Pages: 4008 - 4015

    

33. Prophylactic “First-Step” Central Neck Dissection (Level 6) Does Not Increase Morbidity After (Total) Thyroidectomy

    • Andreas Selberherr
    • Philipp Riss
    • Bruno Niederle

    Endocrine Tumors Open access 08 July 2016 Pages: 4016 - 4022

34. Comparison of Learning Curves for Retroauricular and Transaxillary Endoscopic Hemithyroidectomy

    • Doh Young Lee
    • Dong Ju Oh
    • Kwang-Yoon Jung

    Endocrine Tumors 15 July 2016 Pages: 4023 - 4028

    

35. The Incidence of Unexpected Uterine Malignancy in Women Undergoing Hysterectomy for a Benign Condition: A National Population-Based Study

    • Jin-Sung Yuk
    • Log Young Kim
    • Jung Hun Lee

    Gynecologic Oncology 24 May 2016 Pages: 4029 - 4034

36. Complications of Robotic Gynecologic Surgery in the Severely Morbidly Obese

    • Jonathan A. Cosin
    • Michelle A. Brett Sutherland
    • Hongbin Fang

    Gynecologic Oncology 22 June 2016 Pages: 4035 - 4041

    

37. Intraoperative Sentinel Lymph Node Evaluation: Implications of Cytokeratin 19 Expression for the Adoption of OSNA in Oral Squamous Cell Carcinoma

    • Richard Shaw
    • Anders Christensen
    • Max Robinson

    Head and Neck Oncology Open access 08 July 2016 Pages: 4042 - 4048

    

38. Invasive Scalp Melanoma: Role for Enhanced Detection Through Professional Training

    • Brendan P. Lovasik
    • Ishna Sharma
    • Monica Rizzo

    Melanomas 22 August 2016 Pages: 4049 - 4057

    

39. Pediatric and Adolescent Melanoma: A National Cancer Data Base Update

    • Patrick D. Lorimer
    • Richard L. White
    • Joshua S. Hill

    Melanomas 30 June 2016 Pages: 4058 - 4066

    

40. Improvements in the Treatment of Patients Suffering from Bladder-Prostate Rhabdomyosarcoma: A Report from the CWS-2002P Trial

    • Guido Seitz
    • Jörg Fuchs
    • Ewa Koscielniak

    Pediatric Oncology 07 July 2016 Pages: 4067 - 4072

    

41. Fasciocutaneous Lotus Petal Flap for Perineal Wound Reconstruction after Extralevator Abdominoperineal Excision: Application for Reconstruction of the Pelvic Floor and Creation of a Neovagina

    • Joke Hellinga
    • Patrick C. K. H. Khoe
    • Yassir Eltahir

    Reconstructive Oncology 23 June 2016 Pages: 4073 - 4079

    

42. Postmastectomy Reconstruction Outcomes After Intraoperative Evaluation with Indocyanine Green Angiography Versus Clinical Assessment

    • Gustave K. Diep
    • Jane Yuet Ching Hui
    • Todd M. Tuttle

    Reconstructive Oncology 27 July 2016 Pages: 4080 - 4085

43. Clinical Significance of FDG-PET to Predict Pathologic Tumor Invasion and Lymph Node Metastasis of Superficial Esophageal Squamous Cell Carcinoma

    • Takaoki Furukawa
    • Yoichi Hamai
    • Morihito Okada

    Thoracic Oncology 28 June 2016 Pages: 4086 - 4092

    

44. PSF1 (Partner of SLD Five 1) is a Prognostic Biomarker in Patients with Non-small Cell Lung Cancer Treated with Surgery Following Preoperative Chemotherapy or Chemoradiotherapy

    • Ryu Kanzaki
    • Hisamichi Naito
    • Nobuyuki Takakura

    Thoracic Oncology 05 July 2016 Pages: 4093 - 4100

    

45. Prognostic Significance of Lymphovascular Invasion for Thoracic Esophageal Squamous Cell Carcinoma

    • Shaohua Wang
    • Xiaofeng Chen
    • Lu Lu

    Thoracic Oncology 19 July 2016 Pages: 4101 - 4109

    

46. Phase 1b Trial to Evaluate Tissue Response to a Second Dose of Intravesical Recombinant Adenoviral Interferon α2b Formulated in Syn3 for Failures of Bacillus Calmette–Guerin (BCG) Therapy in Nonmuscle Invasive Bladder Cancer

    • Neema Navai
    • William F. Benedict
    • Colin P. N. Dinney

    Urologic Oncology 07 July 2016 Pages: 4110 - 4114

    

47. High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy

    • Keisuke Shigeta
    • Takeo Kosaka
    • Mototsugu Oya

    Urologic Oncology 30 June 2016 Pages: 4115 - 4122